Therapeutic Reprogramming toward Regenerative Medicine
Chemical Reviews · 26.02.2025 · 125 (4) · 1805-1822
DOI: 10.1021/acs.chemrev.4c00332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Reviews, online erschienen am 05.02.2025. Verfasst von Sheng Ding. Beteiligte Einrichtung: New Cornerstone Science Laboratory, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Regenerative Medicine, Cellular Reprogramming. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Tsinghua University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- New Cornerstone Science Laboratory, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
- Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China.
- Global Health Drug Discovery Institute, Beijing 100192, China.
- CRE Life Institute, Beijing 100192, China.
ORCID-Profile: Sheng Ding
Förderung
- National Key Research and Development Program of China
- Tsinghua University
- National Natural Science Foundation of China
- CRE Life Institute
- New Cornerstone Science Foundation
Zitieren
APA
Ding, S. (2025). Therapeutic Reprogramming toward Regenerative Medicine. Chemical Reviews, 125(4), 1805-1822. https://doi.org/10.1021/acs.chemrev.4c00332
Vancouver
Ding S. Therapeutic Reprogramming toward Regenerative Medicine. Chemical Reviews. 2025;125(4):1805-1822. doi:10.1021/acs.chemrev.4c00332
BibTeX
@article{Ding2025,
author = {Ding, Sheng},
title = {Therapeutic Reprogramming toward Regenerative Medicine},
journal = {Chemical Reviews},
year = {2025},
volume = {125},
number = {4},
pages = {1805--1822},
doi = {10.1021/acs.chemrev.4c00332}
}
EUVIMED